Crossmark

Preoperative Weight Loss Program for Hepatocellular Carcinoma Patients with High Body Mass Index in Hepatectomy

Crossref DOI link: https://doi.org/10.1007/s00268-023-07220-0

Published Online: 2023-10-15

Published Print: 2023-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Saito, Yu

Morine, Yuji

Ikemoto, Tetsuya

Yamada, Shinichiro

Teraoku, Hiroki

Yasui‐Yamada, Sonoko

Nishi, Maki

Sakaue, Hiroshi

Kamada, Motomu

Matsuura, Tetsuya

Shimada, Mitsuo
License Information

Version of Record valid from 2023-10-15

Text and Data Mining valid from 2023-10-15

Version of Record valid from 2023-10-15
More Information

Article History

Accepted: 22 September 2023

First Online: 15 October 2023

Declarations

:

: The authors declare that they have no conflict of interest.

: The study was approved by the Tokushima University Hospital ethics committee and the corresponding regulatory agencies, and all experiments were carried out in accordance with the approved guidelines (Tokushima Clinical Trial Management System Number; 2810, UMIN000026284). All the patients involved in the study signed an informed consent form and agreed to participate.

: Informed consent was obtained from all individual participants included in the study.